Abstract:Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Notably, the incidence of lung cancer among never-smokers, predominantly women, has been rising in recent years. Among the various implicated risk factors, human papilloma virus (HPV) may play a role in the development of NSCLC in a certain subset of patients. The prevalence of high-risk HPV-DNA within human neoplastic lung cells varies across the world; however, the carcinogenetic role of HPV in NSCLC has not been completely understood. Bloodstream could be one of the routes of transmission from infected sites to the lungs, along with oral (through unprotected oral sex) and airborne transmission. Previous studies reported an elevated risk of NSCLC in patients with prior HPV-related tumors, such as cervical, laryngeal, or oropharyngeal cancer, with better prognosis for HPV-positive lung cancers compared to negative forms. On the other hand, 16% of NSCLC patients present circulating HPV-DNA in peripheral blood along with miRNAs expression. Typically, these patients have a poorly differentiated NSCLC, often diagnosed at an advanced stage. However, HPV-positive lung cancers seem to have a better response to target therapies (EGFR) and immune checkpoint inhibitors and show an increased sensitivity to platinum-based treatments. This review summarizes the current evidence regarding the role of HPV in NSCLC development, especially among patients with a history of HPV-related cancers. It also examines the diagnostic and prognostic significance of HPV, investigating new future perspectives to enhance cancer screening, diagnostic protocols, and the development of more targeted therapies tailored to specific cohorts of NSCLC patients with confirmed HPV infection.

What problem does this paper attempt to address?

This paper attempts to explore the role of human papillomavirus (HPV) in the development of non - small - cell lung cancer (NSCLC). Specifically, the paper focuses on the following aspects: 1. **The relationship between HPV infection and NSCLC**: The paper reviews the current evidence on the role of HPV in the development of NSCLC, especially for patients with a history of HPV - related cancers. The study found that HPV infection may play an important role in some NSCLC patients, especially in never - smokers. 2. **The transmission routes of HPV**: The paper discusses the possibilities of how HPV can be transmitted to the lungs through the blood, the oral cavity (such as unprotected oral sex), and the air. These transmission routes may explain why some never - smokers also develop NSCLC. 3. **The epidemiological characteristics of HPV infection**: The paper analyzes the prevalence of HPV infection in different regions and different histological types. For example, the HPV infection rate is the highest in Asia, and the HPV infection rate in squamous cell carcinoma is higher than that in adenocarcinoma. 4. **The diagnostic and prognostic significance of HPV infection**: The paper explores the diagnostic and prognostic value of HPV infection in NSCLC. Studies have shown that HPV - positive NSCLC patients respond better to targeted therapies (such as EGFR inhibitors) and immune checkpoint inhibitors, and are more sensitive to platinum - based chemotherapy. 5. **Future research directions**: The paper also proposes future research directions, aiming to improve cancer screening and diagnostic methods and develop personalized treatment regimens for specific HPV - infected patients. In conclusion, this paper aims to comprehensively summarize the role of HPV in the development of NSCLC, especially in patients with a history of HPV - related cancers, and explore its potential applications in diagnosis, prognosis, and treatment.

The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives

The emerging role of human papillomavirus in lung cancer

HPV and Lung Cancer: A Systematic Review

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study

Investigation on the relevance between human papillomavirus infections and NSCLC

DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW

High-risk human papillomavirus infection in patients with lung cancer and its related mechanism

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities

Relationship between human papillomavirus infection and EGFR mutation in patients with non-small cell lung cancer

HPV and head and neck cancers: Towards early diagnosis and prevention

Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations

Human papillomavirus as a driver of head and neck cancers

Update on Pathologic Conditions, Imaging Findings, Prevention, and Management of Human Papillomavirus-related Neoplasms

Narrative Review on the Current Evidence in the Literature

Molecular mechanisms of human papilloma virus related skin cancers: A review

Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

Human Papillomavirus in Metastatic Lymph Nodes from Unknown Primary Head and Neck Squamous Cell Carcinoma

The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers

Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus

Role of Artificial Intelligence in Human Papillomavirus Status Prediction for Oropharyngeal Cancer: A Scoping Review